Halozyme Therapeutics
HALO
Teradata Corp
TDC
Hutchmed (China)
HCM
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
Dorian LPG
LPG
(FY)Dec 31, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | (FY)Dec 31, 2019 | (FY)Dec 31, 2018 | (FY)Dec 31, 2017 | (FY)Dec 31, 2016 | (FY)Dec 31, 2015 | (FY)Dec 31, 2014 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 55.30%-28.41M | -85.47%-63.56M | -249.45%-34.27M | 55.94%-9.81M | -6.24%-22.26M | 30.56%-20.95M | -83.22%-30.17M | -352.27%-16.47M | -83.84%6.53M | 739.16%40.39M |
Net income from continuing operations | 81.88%-28.71M | -113.01%-158.43M | -131.67%-74.37M | 66.16%-32.1M | -42.04%-94.86M | -37.91%-66.78M | -60.69%-48.42M | 39.66%-30.14M | -297.26%-49.94M | 44.67%25.32M |
Operating gains losses | 45.26%-6.49M | -278.20%-11.86M | -276.53%-3.14M | 15.24%1.78M | 414.92%1.54M | 161.52%299.46K | 97.52%-486.77K | -20,195.83%-19.66M | 30,437.89%97.82K | -100.01%-322.42 |
Depreciation and amortization | -63.86%12.57M | 61.31%34.77M | 178.01%21.55M | -32.23%7.75M | 23.00%11.44M | 53.72%9.3M | 113.15%6.05M | 59.27%2.84M | 7.47%1.78M | 18.15%1.66M |
Deferred tax | --0 | --0 | 32.39%-359K | 50.97%-531K | -124,065.95%-1.08M | -101.41%-872.2198 | 186.84%62.03K | -101.16%-71.43K | 260.03%6.17M | 75.93%-3.86M |
Other non cash items | ---- | 81.54%-2.57M | ---13.94M | ---- | ---- | ---- | ---- | -1,253.67%-200.18K | 96.54%-14.79K | -165.78%-426.88K |
Change In working capital | 73.35%-18.26M | -111.81%-68.51M | -1,581.00%-32.35M | 171.47%2.18M | -126.29%-3.06M | 77.38%-1.35M | -188.98%-5.97M | -67.01%6.71M | 713.43%20.34M | 155.96%2.5M |
-Change in receivables | 31.85%-2.59M | -319.26%-3.8M | --1.73M | --0 | --0 | ---- | ---- | -107.98%-627.9K | 509.22%7.87M | 70.41%-1.92M |
-Change in prepaid assets | -96.79%315K | 524.73%9.81M | -257.18%-2.31M | -33.95%1.47M | -18.71%2.22M | 161.04%2.74M | -241.76%-4.48M | -105.81%-1.31M | 400.13%22.57M | -74.65%-7.52M |
-Change in payables and accrued expense | 161.44%23.63M | -247.62%-38.47M | -483.30%-11.07M | 179.93%2.89M | 11.61%-3.61M | -174.35%-4.09M | -117.22%-1.49M | 185.70%8.65M | -184.52%-10.09M | 88.59%11.94M |
-Change in other current assets | -11.30%-38.04M | -70.25%-34.18M | -59,144.12%-20.08M | -85.89%34K | --241K | --0 | --0 | ---- | ---- | ---- |
-Change in other current liabilities | 15.94%-1.57M | -197.30%-1.87M | 71.49%-629K | -15.56%-2.21M | ---1.91M | --0 | --0 | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 55.30%-28.41M | -85.47%-63.56M | -249.45%-34.27M | 55.94%-9.81M | -6.24%-22.26M | 30.56%-20.95M | -83.22%-30.17M | -352.27%-16.47M | -83.84%6.53M | 739.16%40.39M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 7.29%26.16M | 132.34%24.39M | -2,364.44%-75.41M | -65.31%3.33M | 523.17%9.6M | -115.56%-2.27M | -79.63%14.58M | 150.39%71.57M | -122.63%-142.03M | -844.02%-63.8M |
Net PPE purchase and sale | 89.78%-1.41M | 72.92%-13.78M | -25,222.39%-50.9M | 61.20%-201K | 90.00%-518K | 51.25%-5.18M | -174.59%-10.62M | -148.25%-3.87M | 37.47%-1.56M | -86.54%-2.49M |
Net intangibles purchase and sale | -34.46%22.52M | 216.89%34.35M | --10.84M | --0 | ---- | 53.34%-153.07K | ---328.09K | --0 | 50.81%-136.33K | -303.71%-277.12K |
Net business purchase and sale | --0 | 204.92%5.01M | -125.09%-4.77M | ---2.12M | --0 | 103.64%3.44M | -447.16%-94.66M | 289.92%27.27M | ---14.36M | --0 |
Net investment purchase and sale | 766.14%5.06M | -8.58%-759K | -118.43%-699K | -68.20%3.79M | 3,351.37%11.93M | -99.71%345.54K | 149.53%120.19M | 141.07%48.17M | -103.84%-117.29M | -187.99%-57.54M |
Net other investing changes | ---- | 98.55%-434K | -1,707.21%-29.88M | 202.76%1.86M | -149.48%-1.81M | ---725.11K | ---- | ---- | -149.19%-8.69M | -111.64%-3.49M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 7.29%26.16M | 132.34%24.39M | -2,364.44%-75.41M | -65.31%3.33M | 523.17%9.6M | -115.56%-2.27M | -79.63%14.58M | 150.39%71.57M | -122.63%-142.03M | -844.02%-63.8M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 0 | -61.67%29.77M | 1,941,575.00%77.67M | -99.84%4K | -69.15%2.46M | 544.45%7.96M | 89.37%-1.79M | -114.63%-16.86M | 742.15%115.29M | -80.99%13.69M |
Net issuance payments of debt | --0 | -66.82%6.31M | --19.01M | --0 | --0 | ---- | ---- | ---- | --0 | -197.70%-2.06M |
Net common stock issuance | --0 | -58.20%23.46M | --56.14M | --0 | --0 | 173.13%1.94M | 85.97%-2.65M | -116.77%-18.87M | --112.5M | --0 |
Proceeds from stock option exercised by employees | --0 | --0 | 62,925.00%2.52M | -99.84%4K | -59.25%2.46M | 605.02%6.03M | -52.72%855.15K | -35.23%1.81M | -64.50%2.79M | 1,360.76%7.87M |
Net other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --200.18K | ---- | -27.64%7.89M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | --0 | -61.67%29.77M | 1,941,575.00%77.67M | -99.84%4K | -69.15%2.46M | 544.45%7.96M | 89.37%-1.79M | -114.63%-16.86M | 742.15%115.29M | -80.99%13.69M |
Net cash flow | ||||||||||
Beginning cash position | -68.69%5.57M | -62.83%17.8M | -8.85%47.89M | -16.18%52.54M | -17.09%62.68M | -27.07%75.61M | 75.03%103.67M | -20.82%59.23M | -14.76%74.8M | 1,585.26%87.75M |
Current changes in cash | 76.09%-2.25M | 70.62%-9.41M | -394.52%-32.01M | 36.56%-6.47M | 33.12%-10.2M | 12.24%-15.26M | -145.46%-17.38M | 289.15%38.24M | -108.05%-20.21M | -111.38%-9.72M |
Effect of exchange rate changes | 98.30%-48K | -247.14%-2.83M | 5.26%1.92M | 2,795.24%1.82M | -97.96%63K | 146.61%3.09M | -97,913.38%-6.62M | -99.91%6.77K | 2,837.46%7.14M | 130.60%242.94K |
End cash Position | -41.21%3.28M | -68.69%5.57M | -62.83%17.8M | -8.85%47.89M | -17.17%52.54M | -20.37%63.44M | -18.27%79.66M | 57.93%97.47M | -21.15%61.72M | -12.85%78.28M |
Free cash flow | 43.01%-44.08M | 14.89%-77.34M | -805.80%-90.87M | 56.00%-10.03M | 13.26%-22.8M | 36.91%-26.28M | -104.85%-41.66M | -522.16%-20.34M | -87.19%4.82M | 1,060.67%37.62M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion |